304 related articles for article (PubMed ID: 33799604)
1. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
[TBL] [Abstract][Full Text] [Related]
2. Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.
Li X; Pham V; Tippin M; Fu D; Rendon R; Song L; Uchio E; Hoang BH; Zi X
Cell Commun Signal; 2019 Mar; 17(1):25. PubMed ID: 30885218
[TBL] [Abstract][Full Text] [Related]
3. Skp2 is associated with paclitaxel resistance in prostate cancer cells.
Yang Y; Lu Y; Wang L; Mizokami A; Keller ET; Zhang J; Fu J
Oncol Rep; 2016 Jul; 36(1):559-66. PubMed ID: 27175797
[TBL] [Abstract][Full Text] [Related]
4. High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells.
Šimečková Š; Kahounová Z; Fedr R; Remšík J; Slabáková E; Suchánková T; Procházková J; Bouchal J; Kharaishvili G; Král M; Beneš P; Souček K
Sci Rep; 2019 Apr; 9(1):5695. PubMed ID: 30952903
[TBL] [Abstract][Full Text] [Related]
5. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model.
Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X
Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688
[TBL] [Abstract][Full Text] [Related]
6. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
7. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
[TBL] [Abstract][Full Text] [Related]
8. Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy.
Pham V; Rendon R; Le VX; Tippin M; Fu DJ; Le TH; Miller M; Agredano E; Cedano J; Zi X
Mol Carcinog; 2020 Feb; 59(2):193-201. PubMed ID: 31782573
[TBL] [Abstract][Full Text] [Related]
9. Chronic hypoxia-induced slug promotes invasive behavior of prostate cancer cells by activating expression of ephrin-B1.
Iwasaki K; Ninomiya R; Shin T; Nomura T; Kajiwara T; Hijiya N; Moriyama M; Mimata H; Hamada F
Cancer Sci; 2018 Oct; 109(10):3159-3170. PubMed ID: 30058095
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
[TBL] [Abstract][Full Text] [Related]
11. The novel protective role of P27 in MLN4924-treated gastric cancer cells.
Zhang Q; Hou D; Luo Z; Chen P; Lv B; Wu L; Ma Y; Chu Y; Liu H; Liu F; Yu S; Zhang J; Yang D; Liu J
Cell Death Dis; 2015 Aug; 6(8):e1867. PubMed ID: 26313918
[TBL] [Abstract][Full Text] [Related]
12. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.
Brown LK; Kanagasabai T; Li G; Celada SI; Rumph JT; Adunyah SE; Stewart LV; Chen Z
Prostate; 2024 Jun; 84(9):877-887. PubMed ID: 38605532
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neddylation facilitates cell migration through enhanced phosphorylation of caveolin-1 in PC3 and U373MG cells.
Park SY; Park JW; Lee GW; Li L; Chun YS
BMC Cancer; 2018 Jan; 18(1):30. PubMed ID: 29301501
[TBL] [Abstract][Full Text] [Related]
14. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L
Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells.
Fontana F; Raimondi M; Marzagalli M; Sommariva M; Limonta P; Gagliano N
Cells; 2019 Feb; 8(2):. PubMed ID: 30754655
[TBL] [Abstract][Full Text] [Related]
18. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
van Duijn PW; Trapman J
Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
[TBL] [Abstract][Full Text] [Related]
19. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
[TBL] [Abstract][Full Text] [Related]
20. Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.
Xie Y; Liu S; Lu W; Yang Q; Williams KD; Binhazim AA; Carver BS; Matusik RJ; Chen Z
Mol Oncol; 2014 Oct; 8(7):1355-64. PubMed ID: 24910389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
